Navigation Links
Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
Date:6/1/2009

>

Pixantrone is also now available in Europe on a named patient basis.

About Pixantrone

Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines are the cornerstone therapeutic for the treatment of lymphoma, leukemia, and breast cancer. Although they are sufficiently effective to be used as first-line (initial) treatment, they cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a lifetime limit of anthracycline doses and most patients who previously have been treated with an anthracycline are not able to receive further anthracycline treatment if their disease returns. It also can be administered through a peripheral vein rather than a central implanted catheter as required for other drugs in this class.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.

Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_news

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties that could affect the development of pixantrone include risks associated with preclinical and clinical developments in the biopharmaceutic
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Discussions With FDA on Pixantrone EXTEND (PIX301) Trial Provide Path for NDA Submission
2. Cell Therapeutics Targeting Potential Zevalin Label Expansion, Pixantrone and OPAXIO Drug Approvals to Grow Commercial Operations and Revenues in 2009
3. Low Occurrence of Severe Cardiac Side Effects Despite Extensive Prior Doxorubicin Treatment Reported in Pixantrone Pivotal Trial
4. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
5. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
6. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
7. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
8. New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
9. Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
10. Cord Blood America CEO Matthew Schissler Says Operations Significantly Streamlined
11. Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... 2014 Reflecting the importance of the evolution ... Connie Rankin, the founder and president of Customized ... introduced a fresh new approach to the firm’s branding. ... to influence the success of his or her commercial clients ... one of the first in this market to fully embrace ...
(Date:7/18/2014)... 18, 2014 Global biotechnology company ... offices in Cambridge, MA, announces the launch of ... Software product that leverages the power of Next ... MiSeq sequencing platform. The assay and software have ... of Philadelphia (CHOP) and will include a new ...
(Date:7/18/2014)... 18, 2014  On July 18, 2014, ... Shire,s complementary fit and the benefits of ... of the infographic materials will be available ... In accordance with Rule 30.4 ... this announcement will be available on AbbVie,s ...
(Date:7/18/2014)... -- The Basel Declaration presented the ... consecutive year. The award winner, Vladimir Sergeevich Popov from ... at Zürich University for research with animals according to ... head of the animal research laboratory at the Moscow ... adapting experimental animal research as well as student training ...
Breaking Biology Technology:LEED AP Certified ITRA Global / Customized Real Estate Services Introduces New Approach to Its Branding 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 3NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 2NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 3NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 4NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 5NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 6NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 7Young Moscovite Researcher Receives this Year's "Basel Declaration Award for Education in Animal Research" 2
... designed a micro aircraft that will be able to ... the Biomimetics-Innovation-Centre in Germany have been inspired by birds ... vehicle (MAV) that combines flapping wings, which allow it ... ability to glide, ensuring good quality images from any ...
... new class of therapeutics, known as recombinant attenuated ... fight against fatal diseases including hepatitis B, tuberculosis, cholera, ... and his colleagues at the Biodesign Institute at Arizona ... vaccines safer and more effective. The group, under the ...
... Physics World, which examines the science and applications of invisibility, ... a new type of invisibility cloak that does not just ... heist as an example, McCall and Kinsler explain how a ... money from a safe, without even the CCTV surveillance cameras ...
Cached Biology Technology:New salmonella-based 'clean vaccines' aid the fight against infectious disease 2New salmonella-based 'clean vaccines' aid the fight against infectious disease 3Why 'event cloaks' could be the key to the ultimate bank heist 2
(Date:7/21/2014)... A team of University of California, Riverside Bourns College of ... the grates of a backyard grill reduces by 70 percent ... The one-eighth inch thick steel carbon plate with an insulated ... a slit into the grill to allow the plate to ... by grill manufacturers who could sell new grills with the ...
(Date:7/21/2014)... Lgar,s team at the INRS nergie Matriaux Tlcommunications ... a spatial and temporal resolution greatly exceeding that ... a femtosecond laser source to shoot a molecular ... vinylidene. An article presenting the advancement was recently ... . , "The approach we developed combines ...
(Date:7/21/2014)... to climate change, due to greenhouse gasses emitted by ... the rise and that beef cattle are responsible for ... animals. It is published by Climactic Change . ... it comes to climate change. It is released by ... portion of greenhouse gas totals. But methane and nitrous ...
Breaking Biology News(10 mins):Catching grease to cut grill pollution 2Climate: Meat turns up the heat 2
... ,The oil spill from the Prestige petroleum oil ... the Bay of Biscay. A PhD thesis at the University ... this spill for the mussels inhabiting this northern coast of ... is the biologist Ms Larraitz Garmendia Altuna, who entitled her ...
... lighting more bush fires, ecologists have proposed. The ... by encroaching woodland that is destroying their habitat, a ... Stanford University (USA) has shown. "Broad-headed snakes are ... of Sydney, and those small communities are fast becoming ...
... newswire / – To cope with the most ... to explore the different varieties of standard-issue business strategies ... strategy of following the "order of practice of the ... budgets and other radical cost-cutting measures. The consequence of ...
Cached Biology News:The Prestige oil spill caused changes in the cell structure of mussels 2Australia's most endangered snake might need burning 2Recession Puts Focus on Business Optimisation and Excellence to Strengthen Business Core 2
Recombinant Mouse MMP-9, CF...
Phosphorylcholine hapten is conjugated to BSA protein by use of p-diazonium phenylphosphorylcholine....
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
TAR DNA binding protein...
Biology Products: